U.K. government to increase NTD spending fivefold between 2011 and 2015

"The U.K. government has announced a fivefold increase in spending on combating neglected tropical diseases [NTDs] as part of an international effort to help rid the world of a group of infectious diseases that currently affect one billion people and kill more than half a million every year," BMJ reports (Moszynski, 1/23). "International Development Minister Stephen O'Brien said funding for [NTDs] is to increase from £50 million to £245 million [approximately $381.5 million] between 2011 and 2015 as part of a global push to eradicate diseases including river blindness and elephantiasis," the Press Association writes.

"The extra money will help supply more than four treatments every second for people in the developing world for the next four years, protecting more than 140 million people," according to the news agency, which adds the programs will focus on lymphatic filariasis (elephantiasis), onchocerciasis (river blindness), schistosomiasis (bilharzia) and dracunculiasis (Guinea worm) (1/21). The announcement "comes ahead of a conference in London on January 30 when the Bill & Melinda Gates Foundation, governments, [non-governmental organizations], multilateral organizations and the private sector will unite to help consign the diseases to history," according to a U.K. Department for International Development (DFID) press release (.pdf) (1/21).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New toolkit aims to help U.S. hospitals spot deadly viral hemorrhagic fevers faster and safer